158
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Periconceptional folic acid and teratogenic drug use in women undergoing fertility treatments

&
Pages 1899-1903 | Received 14 Jan 2012, Accepted 17 Feb 2012, Published online: 28 Mar 2012

References

  • Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf 2011;20:895–902.
  • Dunlop AL, Gardiner PM, Shellhaas CS, Menard MK, McDiarmid MA. The clinical content of preconception care: the use of medications and supplements among women of reproductive age. Am J Obstet Gynecol 2008;199:S367–S372.
  • De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010:CD007950.
  • Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006;28:680–689.
  • Czeizel AE, Bánhidy F. Vitamin supply in pregnancy for prevention of congenital birth defects. Curr Opin Clin Nutr Metab Care 2011;14:291–296.
  • Use of supplements containing folic acid among women of childbearing age--United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:5–8.
  • Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005;330:571.
  • Amitai Y, Fisher N, Meiraz H, Baram N, Tounis M, Leventhal A. Preconceptional folic acid utilization in Israel: five years after the guidelines. Prev Med 2008;46:166–169.
  • Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, Blight C, et al.; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada and The Motherrisk Program. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003–1026.
  • Clutton-Brock TH, Lewis G. Saving mothers’ lives reviewing maternal deaths to make motherhood safer- 2003–2005: the seventh report of the confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH; 2007.
  • Gardiner PM, Nelson L, Shellhaas CS, Dunlop AL, Long R, Andrist S, Jack BW. The clinical content of preconception care: nutrition and dietary supplements. Am J Obstet Gynecol 2008;199:S345–S356.
  • Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation a reference guide to fetal and neonatal risk. 2008;8th edn.
  • Dunlop AL, Jack BW, Bottalico JN, Lu MC, James A, Shellhaas CS, Hallstrom LH, et al. The clinical content of preconception care: women with chronic medical conditions. Am J Obstet Gynecol 2008;199:S310–S327.
  • Frishman GN, Spurrell TP, Heber WW. Folic acid. Preconception knowledge and use by infertile women. J Reprod Med 2001;46:1025–1030.
  • Paulik E, Császár J, Kozinszky Z, Nagymajtényi L. Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant women. Eur J Obstet Gynecol Reprod Biol 2009;145:49–52.
  • Ludwig AK, Katalinic A, Steinbicker V, Diedrich K, Ludwig M. Antenatal care in singleton pregnancies after ICSI as compared to spontaneous conception: data from a prospective controlled cohort study in Germany. Hum Reprod 2006;21:713–720.
  • Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, Ueland PM. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr 2006;84:1134–1141.
  • Riskin-Mashiah S, Auslander R. Quality of medical care in diabetic women undergoing fertility treatment: we should do better! Diabetes Care 2011;34:2164–2169.
  • Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398–407.
  • Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB. Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006;15:555–564.
  • Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription of hazardous drugs during pregnancy. Drug Saf 2004;27:899–908.
  • Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf 2010;19:408–417.
  • Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2011;20:243–248.
  • ACOG Committee Opinion number 313, September 2005. The importance of preconception care in the continuum of women’s health care. Obstet Gynecol 2005;106:665–666.
  • Segev Y, Riskin-Mashiah S, Lavie O, Auslender R. Assisted reproductive technologies: medical safety issues in the older woman. J Womens Health (Larchmt) 2011;20:853–861.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.